To Top

Community

Steve Kuehn

Steve offers the life science industry insight and perspective from his more than 30 years of editorial, corporate and agency communications experience. Drawing from tenure as a lead communicator and media relations director for one of world’s largest technology and engineering companies, as well the editorial leadership of industry-leading B2B journals serving the energy, transportation and pharmaceutical sectors, including Pharmaceutical Manufacturing magazine, Steve delivers brand strategy, market-moving content and decision support. Steve holds a Bachelor of Science degree from Ohio University.

Contribution
Drug Development

Promacta Gets Breakthrough Therapy Designation

PAO-M01-18-NI-012
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Clinical Trials

Findings Suggest Low-Cal Sweeteners Pose No Increased Diabetes Risk

PAO-M09-17-NI-023
Road to BIO

The Road to BIO in Review

PAP-Q3-17-RB-001
API

Cambrex Invests in New Highly Potent API Manufacturing Capacity

PAO-M08-17-NI-016
Collaboration

Collaboration Targets Vaccine Technologies to Wipe out HIV-1 and Hep-B

PAO-M08-17-NI-013
Manufacturing

Lonza Pharm&Biotech Constructing Manufacturing Complex in Switzerland

PAO-M08-17-NI-003
FDA

Lilly’s Breast Cancer Treatment Granted Priority Review

PAO-M07-17-NI-019
Acquisition

Agilent Acquires Cobalt, a Raman Innovator

PAO-M07-17-NI-013
FDA

Breckenridge Wins ANDA for Azacitidine

PAO-M07-17-NI-001
CRO

CRO’s Move to Fill the Gap

PAO-M06-17-NI-006
Continuous Manufacturing

Cardio Candidate to be Manufactured Continuously

PAO-M06-17-NI-003
Pharma

Top Biotech Companies at Home in Ireland

PAO-M05-17-NI-035
Oncology

Common Biomarker Guides New Cancer Therapy

PAO-M05-17-NI-033
Innovation

Pharma’s Back to Nature Trend

PAO-M05-17-NI-028
Business

US Spending on Medicines Slows by Half, According to Study

PAO-M05-17-NI-017
Innovation

Inside the Immune System 

PAO-M05-17-NI-014
Pharma

BIO Applauds USTR’s 2017 Special 301 Report on Global Challenges to IP

PAO-M05-17-NI-009
Innovation

Medical Cannabis Continues to Cultivate Innovation

PAO-M04-17-NI-028
CDMO

Bioprocessing Capacity is in High Demand

PAO-M04-17-NI-022
CDMO

Rentschler Sharpens its Competitive Edge

PAO-M04-17-NI-017
Discovery

Inovio Ebola DNA Vaccine Demonstrates Robust Immune Response

PAO-M04-17-NI-012
CDMO

Sartorius Acquires Umetrics

PAO-M04-17-NI-010
CDMO

Avista Pharma Solutions Completes $4 Million Expansion

PAO-M04-17-NI-002
CDMO

Sanofi, Lonza Invest in Large-Scale Biologics Partnership

PAO-M03-17-NI-007
Equipment

Stay Tuned: Pharma’s Almanac TV Goes Live

PAP-Q1-17-PT-001
Biologics

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001
API

Future Pharma Partner Models: Pharma 3.0

PAP-Q03-16-FA-001
CDMO

Pharma’s Renaissance Continues

PAP-Q03-16-ED-001
Equipment

Pharma Equipment Budget Expansion Fueling Quest For Operational Excellence

APR-M06-16-NI-001